Anastrozole API Powder

Anastrozole API Powder Non-Steroidal Aromatase Inhibitor for Breast Cancer Formulations Narix Pharmaceuticals Narix Pharmaceuticals supplies Anastrozole API Powder for manufacturing Arimidex equivalent tablets first-line adjuvant aromatase inhibitor for postmenopausal HR+ early and advanced breast cancer. Technical Specifications: CAS Number: 120511-73-1 Purity: Greater than 99% Grade Standard: USP Form: White powder MOQ: 1 Kg Applications: Anastrozole 1mg tablet manufacturing, adjuvant breast cancer therapy, aromatase inhibitor formulations Storage: Cool, dry, airtight storage #AnastrozoleAPI #AromataseInhibitorAPI #BreastCancerAPIManufacturer #ArimidexAPIManufacturer #WHOGMPCertified #NarixPharmaceuticals About the Company GST Registration Date: 2023 Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 1.5 - 5 Cr company-description: Established in the year of 2016, We "Narix Pharmaceuticals Private Limited" are Wholesaler Exporter, Distributor, Importer and Supplier of an Pharmaceutical Tablets, Oral Jelly, Pharmaceutical Capsules, Pharmaceutical Soap, Pharmaceutical Cream, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.For our accomplishment story, we are grateful to our Mr. Naman, whose continual backing and direction have been useful to us for attaining exponential development in the current market.